Quarter Financials
ASLAN Pharmaceuticals Limited (ASLN)
$3.78
-0.06 (-1.56%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2021 Q3
|
2021 Q2
|
2020 Q3
|
2020 Q2
|
2019 Q3
|
2019 Q2
|
|---|
| Net Income | -11 | -13 | -9 | -5 | -3 | -4 | -5 | -8 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -264 | -253 | -216 | -208 | -190 | -186 | -150 | -145 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2021 Q3
|
2021 Q2
|
2020 Q3
|
2020 Q2
|
2019 Q3
|
2019 Q2
|
|---|
| Capital Expenditure | - | - | - | - | - | - | -0 | - |
|---|
| Net PPE | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2021 Q3
|
2021 Q2
|
2020 Q3
|
2020 Q2
|
2019 Q3
|
2019 Q2
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|